GMPs: FDA Looked Beyond U.S., Transparency Tweaked in 2011

Executive Briefing Series
Efforts to secure the global drug supply chain were a key FDA concern in 2011, with the agency urging drugmakers to tighten supplier controls and aim high in their audits of foreign contractors.

To View This Article:


Buy This Article Now

Add this article to your cart for $40.00